Cytotherapy 2013

Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease-results of the short- and long-term follow-up

G.V. Szabó, Z. Kövesd, J. Cserepes, J. DaróczyM. Belkin M, and G. Acsády

BioProcessing Journal 2007

Challenges in the Development of Autologous Cell Therapy Products

Y. Porat, D. Belkin, A. Belleli, J. Elkayam, D. Shimoni, S. Porozov, I. Sarel, I. Ash, and V. Fulga

Hemostemix ACP-01 Publication

Autologous Stem Cell Treatment For CLI Patients With No Revascularization Options
(An Update of the Hemostemix ACP-01 Trial With 4.5 Year Followup)

Jonathan Misskey MD MHPE FRCSC, Lynn Cunada, RN, Kyle Makofka, Alan Jacobs MSEE MD PhD,
Thomas Lindsay MDCM, MSc, FRCSC, York N. Hsiang, MB ChB, MHSc., FRCSCS

Asian Annals

Intramyocardial Angiogenic Cell Precursor Injection for Cardiomyopathy
Kitipan V Arom, Permyos Ruengsakulrach and Vibul Jotisakulratana
Asian Cardiovasc Thorac Ann 2008;16:143-148

BJH research paper

Isolation of an adult blood-derived progenitor cell population
capable of differentiation into angiogenic, myocardial and
neural lineages

Panama College of Cell Science

Transcoronary Injection of Angiogenic Cells Precursors an Autologous Stem Cell in Ischemic Cardiomyopathy: A Clinical study of 106 cases in Thailand